Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Response's proposal to creditors approved:

This article was originally published in Clinica

Executive Summary

Response Biomedical has learnt that the British Columbia Supreme Court has approved the company's proposal to its creditors. The approval will trigger the second tranche of a bridge financing, which totals $500,000. The balance of the loan will be paid once the company receives FDA clearance for its RAMP reader and myoglobin assay test. The company went into bankruptcy in September after the FDA rejected its product (see Clinica No 976, p 13). It is believed the rejection prompted some of the Vancouver, British Columbia company's creditors to demand repayment.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074346

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel